By Abaire Bisola
Former President Donald Trump has announced new tariffs on Mexico, Canada, and China as part of efforts to curb the fentanyl crisis, the leading cause of death among Americans aged 18 to 45.
The tariffs include a 25% levy on Mexican goods, a 10% tariff on Canadian energy resources, and a 10% duty on Chinese imports, aimed at pressuring these nations to intensify their fight against drug trafficking.
The move targets Mexican cartels, the primary traffickers of fentanyl into the U.S., while also addressing concerns over fentanyl production in Canada.
The Trump administration insists that international cooperation is essential to stemming the flow of dangerous substances into the country.
While the tariffs are framed as a national security measure, they have sparked concerns over potential economic repercussions and increased consumer costs.
The administration has warned that non-compliance by these countries could result in escalating tariffs, raising fears of global trade tensions.
Supporters argue that Trump’s tariff policies have historically bolstered the U.S. economy, citing a 2024 study linking them to increased domestic manufacturing.
However, the economic impact remains debated, with experts divided on whether tariffs ultimately benefit or burden American consumers.
